表紙
市場調查報告書

微型角膜刀市場 - 規模、佔有率、展望、機會分析 (2020-2027年):各終端用戶、治療、地區

Microkeratome Market, by Product, by End User, by Treatment, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 948403
出版日期 內容資訊 英文 160 Pages
商品交期: 2-3個工作天內
價格
微型角膜刀市場 - 規模、佔有率、展望、機會分析 (2020-2027年):各終端用戶、治療、地區 Microkeratome Market, by Product, by End User, by Treatment, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月03日內容資訊: 英文 160 Pages
簡介

由於眼科疾病的盛行率的上升和老年人口增加等要素,預計今後促進微型角膜刀市場成長。根據世界衛生組織(WHO),視力障礙的主要原因,是未矯正的白內障及屈光異常。 2019年,約有22億人患眼科疾病或視覺障礙病。亞太地區的各種國的政府,由於投資改善醫療保健基礎設施,預計在預測期間內推動市場成長。再加上各種國的政府與眼科疾病提高視覺障礙相關意識。可是,熟練的專家的不足,預計抑制在預測期間內,市場成長。

本報告提供全球微型角膜刀市場相關調查,市場概要,影響市場的因素分析,各市場區隔、各地區的市場分析,並提供主要企業簡介等資訊。

第1章 調查目的、前提條件

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細 :各產品
    • 市場明細 :終端用戶
    • 市場明細 :各治療
    • 市場明細 :各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 屈光矯正手術的技術進步
  • 主要的發展
  • 收購,合作,夥伴關係
  • 流行病學

第4章 全球微型角膜刀市場,冠狀病毒(Covid-19)的影響

  • COVID的前狀況
  • COVID後的需求
  • 微型角膜刀的需求
  • 推薦事項與指南:各法規當局

第5章 全球微型角膜刀市場:各產品

  • 簡介
  • 可重複使用
  • 拋棄式

第6章 全球微型角膜刀市場:各終端用戶

  • 簡介
  • 醫院
  • 眼科中心
  • 其他

第7章 全球微型角膜刀市場:各治療

  • 簡介
  • 視網膜剝離
  • 視網膜上薄膜
  • 糖尿病視網膜病變
  • 其他

第8章 全球微型角膜刀市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第9章 競爭情形

  • 企業簡介
    • Essilor International
    • Bausch & Lomb Incorporated
    • Johnson & Johnson Vision Care
    • CooperVision
    • Carl Zeiss AG
    • Hoya株式會社
    • Alcon, Inc.
    • STAAR Surgical Company
    • Marvel Medtech
    • Abbott Medical Optics Inc.
    • Novartis AG
    • HAAG-Streit Holding AG
    • NIDEK CO., LTD.
    • Valeant Pharmaceuticals International, Inc.
    • Sonomed Escalon
    • Topcon Corporation
    • Gulden Ophthalmics
    • FCI Ophthalmics
    • Ziemer Ophthalmic Systems AG
    • Glaukos Corporation

第10章 Section

目錄

Title:
Microkeratome Market, by Product (Reusable and Disposable), by End User (Hospitals, Ophthalmic Centers, and Others), by Treatment (Retinal Detachment, Diabetic Retinopathy, Epiretinal membrane, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

A microkeratome is a high-precision surgical instrument used for Anterior Lamellar Keratoplasty (ALK) or Laser Eye Surgery (LASIK). A microkeratome comprises of an oscillating blade that is intended to create the corneal flap for surgeries allied to refractive errors. This surgical instrument is used in DSAEK (Descemet's Stripping Automated Endothelial Keratoplasty) to cut a reedy layer from the cornea's back which is then relocated into the inheritor's cornea. The microkeratome and vacuum units are assembled, tested, and inspected before the surgery, , to confirm appropriate functioning.

Market Dynamics

Factors such as the rising prevalence of eye disorders and the growing geriatric population are expected to propel the microkeratome market growth in the future. According to the World Health Organization (WHO), uncorrected cataracts and refractive errors are the leading cause of vision impairment. In 2019, there were around 2.2 billion people suffering from eye disorders or vision impairment.

Governments of various countries in Asia Pacific are investing in improving healthcare infrastructure which is estimated to fuel market growth during the forecast period.

Moreover, governments of various countries are promoting awareness regarding eye disorders and vision impairment. However, the dearth of skilled professionals is predicted to restrict the market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global microkeratome market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global microkeratome market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study are Essilor International, Bausch & Lomb Incorporated, Johnson & Johnson Vision Care, CooperVision, Carl Zeiss AG, Hoya Corporation, Alcon, Inc., STAAR Surgical Company, Marvel Medtech, Abbott Medical Optics Inc., Novartis AG, HAAG-Streit Holding AG, Nidek Co., Ltd., Valeant Pharmaceuticals International, Inc., Sonomed Escalon, Topcon Corporation, Gulden Ophthalmics, FCI Ophthalmics, Ziemer Ophthalmic Systems AG, and Glaukos Corporation
  • Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global microkeratome market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for microkeratome market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Microkeratome Market, By Product:
    • Reusable
    • Disposable
  • Global Microkeratome Market, By End User:
    • Hospitals
    • Ophthalmic Centers
    • Others
  • Global Microkeratome Market, By Treatment:
    • Retinal Detachment
    • Epiretinal Membrane
    • Diabetic Retinopathy
    • Others
  • Global Microkeratome Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Product:
    • Reusable
    • Disposable
    • Orthopedic
    • Others
      • By End User:
    • Hospitals
    • Ophthalmic Centers
    • Others
      • By Treatment:
    • Retinal Detachment
    • Epiretinal Membrane
    • Diabetic Retinopathy
    • Others
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Product:
    • Reusable
    • Disposable
    • Orthopedic
    • Others
      • By End User:
    • Hospitals
    • Ophthalmic Centers
    • Others
      • By Treatment:
    • Retinal Detachment
    • Epiretinal Membrane
    • Diabetic Retinopathy
    • Others
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Product:
    • Reusable
    • Disposable
    • Orthopedic
    • Others
      • By End User:
    • Hospitals
    • Ophthalmic Centers
    • Others
      • By Treatment:
    • Retinal Detachment
    • Epiretinal Membrane
    • Diabetic Retinopathy
    • Others
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Product:
    • Reusable
    • Disposable
    • Orthopedic
    • Others
      • By End User:
    • Hospitals
    • Ophthalmic Centers
    • Others
      • By Treatment:
    • Retinal Detachment
    • Epiretinal Membrane
    • Diabetic Retinopathy
    • Others
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Product:
    • Reusable
    • Disposable
    • Orthopedic
    • Others
      • By End User:
    • Hospitals
    • Ophthalmic Centers
    • Others
      • By Treatment:
    • Retinal Detachment
    • Epiretinal Membrane
    • Diabetic Retinopathy
    • Others
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Product:
    • Reusable
    • Disposable
    • Orthopedic
    • Others
      • By End User:
    • Hospitals
    • Ophthalmic Centers
    • Others
      • By Treatment:
    • Retinal Detachment
    • Epiretinal Membrane
    • Diabetic Retinopathy
    • Others
  • Company Profiles
    • Essilor International
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Johnson & Johnson Vision Care
    • Bausch & Lomb Incorporated
    • CooperVision
    • Hoya Corporation
    • Carl Zeiss AG
    • Alcon, Inc.
    • Marvel Medtech
    • STAAR Surgical Company
    • Abbott Medical Optics Inc.
    • Novartis AG
    • HAAG-Streit Holding AG
    • Nidek Co., Ltd.
    • Topcon Corporation
    • Valeant Pharmaceuticals International, Inc.
    • Ziemer Ophthalmic Systems AG
    • Sonomed Escalon
    • Gulden Ophthalmics
    • FCI Ophthalmics
    • Glaukos Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By End User
    • Market Snippet, By Treatment
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Technological Advancements for Refractive Surgery
  • Key Developments
  • Acquisition, Collaborations & Partnerships
  • Epidemiology

4. Global Microkeratome Market, Impact of Coronavirus (Covid-19) Pandemic

  • Pre-COVID situation
  • Post-COVID demand
  • Need for Microkeratome
  • Recommendations and guidelines by regulatory bodies

5. Global Microkeratome Market, By Product, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Reusable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Disposable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Microkeratome Market, By End User, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Ophthalmic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Microkeratome Market, By Treatment, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Retinal Detachment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Epiretinal Membrane
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Diabetic Retinopathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Microkeratome Market, By Region, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027(%)
    • Y-o-Y Growth Analysis, By Region, 2017 -2027
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Company Profiles
    • Essilor International
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bausch & Lomb Incorporated
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Johnson & Johnson Vision Care
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • CooperVision
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Carl Zeiss AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Hoya Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Alcon, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • STAAR Surgical Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Marvel Medtech
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Abbott Medical Optics Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • HAAG-Streit Holding AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Nidek Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Valeant Pharmaceuticals International, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Sonomed Escalon
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Topcon Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Gulden Ophthalmics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • FCI Ophthalmics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Ziemer Ophthalmic Systems AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Glaukos Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact